精确癌症医学基因组分析的微投放研究:来自挪威国家精确诊断基础设施的应用
Pia S Henkel1, Eline Aas2, Hege G Russnes3
1Institute of Health and Society, University of Oslo, Oslo, Norway.
The Journal of molecular diagnostics : JMD
|July 25, 2025
概括
这项研究开发了一种灵活的成本框架,用于精密癌症医学中的基因组分析. 它发现消耗品和人员是主要的成本驱动因素,自动化提供了潜在的节省.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 卫生经济学 卫生经济学
背景情况:
- 基因组分析对精确的癌症医学至关重要.
- 战略规划和成本效益评估需要准确的成本分析.
研究的目的:
- 开发和应用微成本基因组分析的灵活成本框架.
- 分析与TruSight瘤500面板及其集成到分子瘤板中的成本.
主要方法:
- 开发了微成本基因组分析的动态成本框架.
- 利用现场访问和员工讨论以验证工作流程和资源输入.
- 对资源使用,批量大小和自动化投资进行了敏感性分析.
主要成果:
- 每个样本的总成本为2944美元,范围为2366美元至4307美元.
- 消耗品和人员是最重要的成本类别.
- 自动化图书馆准备使每个样本的成本降低到2881美元,在更大的批量大小.
结论:
- 成本计算框架展示了设备和批量大小对基因组分析成本的影响.
- 耗材和人员提供了最大的成本降低潜力.
- 必须解决人员瓶问题,以提高产能.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
06:40Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
1.4K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
